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INTRODUCTION 
According to the World Health 
Organization, stroke or cerebro-vascular 
accident (CVA) has been defined as a 
syndrome of rapidly developing clinical 
symptoms and signs of focal (or global) 
loss of cerebral functions, with symptoms 
lasting 24 hours or longer or resulting in 
death with no apparent cause other than 
of vascular origin1,2. Stroke is a major 
challenge to physicians worldwide, with 
high incidence, mortality, disability rates, 
and costs.3  
It remains the third leading cause of 
death in the United States and the 
leading cause of serious long-term 
disability worldwide4,5.  It is estimated that 
700,000 American residents experience 
a new or recurrent stroke, with an 
estimated 500,000 having their first 
stroke4. This disease was thought to be 
rare in the black Africans five decades 
ago6, but strong evidences supports an 
emerging epidemic of stroke in 
developing countries following social 
and economic re-structuring over the 
next few decades. 
Though the situation in sub-Saharan 
Africa is peculiar as significant mortality 
accrues to infectious diseases such as 
human immuno-deficiency virus/ acquired 
immune-deficiency syndrome (HIV/AIDS) 
and malaria, there are however reports 
indicating that stroke had become the 
leading cause of neurological 
admissions in most tertiary hospitals in 
Nigeria, taking over from central 
nervous system infections reported in 
earlier studies7,8,9,10.  Stroke accounted 
for 0.92 – 4% of hospital admissions 
and 2.83 – 4.52% of total deaths in 
Nigeria11. 
The actual incidence of stroke in 
Nigeria has not been established but 
there are indications that the incidence 
is likely to be high and the mortality 
increasing as in other African countries. 
In a community study of neurological 
disorders among Nigerians, Osuntokun 
et al 12 reported a crude prevalence rate 
of 58 per 100,000 of population, similar 
to the figure by Matenga13 in Zimbabwe.  
More recently, community surveys 
undertaken in South Africa14, Togo15 
and Tanzania16,17 suggest the prevalence 
of stroke to be between 200 and 300 per 
100,000. 
 In industrialized countries, stroke 
accounted for 10-12 percent of all 
deaths, with about 88% of the deaths 
attributed to stroke occurring among 
people over 65 years5. It appears 
however that death rates from stroke 
have been falling dramatically in recent 
decades in developed nations, with Japan 
experiencing the most precipitations 
fall18.  This change in trend is not 
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unlikely to be related to the changing 
risk factor levels over time. 
Stroke Types 
Stroke is caused by disruption in the 
flow of blood to part of the brain 
(ischemic-thrombotic) resulting in 
hypoxia and eventually necrosis.  It may 
also be due to occlusion of a blood 
vessel (ischemic-embolic) or rupture of 
a blood vessel (hemorrhagic). About 80 
percent of all acute strokes are caused 
by cerebral ischemia, usually resulting 
from thrombotic or embolic occlusion of 
a cerebral artery, the remaining 20 
percent are caused by intra-cerebral or 
subarachnoid hemorrhage. Categories 
of ischemic stroke include (a) large 
vessel disease (atherothrombosis) (b) 
small vessel disease (microatheromatosis) 
and (c) cardio – embolic.  The large 
vessel disease comprises 30-35%, the 
small vessel type 15 – 25%, cardio-
embolic 15%, arterial dissection (with 
vasculitides and hypercoagulable states) 
contribute 5 -10% while the remaining 
20 – 25% are of unknown etiology. 
Cost constraints and limited 
availability of computerized tomography 
(CT) imaging considerably restrict 
information on the profile of different 
pathologic types of stroke in sub-
Saharan Africa. In many hospitals, CT 
scan is only performed in about 50 
percent of all patients presenting with 
stroke, and usually only among those 
who can afford it19. The South African 
MEDUNSA stroke register20 showed 
that cerebral infarction accounted for 
71% of stroke cases in South African 
blacks. On the other hand however, 
intra-cerebral bleed accounted for 60 
percent of strokes in a series of over 
900 CT – confirmed cases of stroke in 
Ghana21.  Similar trend of high rate of 
intra-cerebral bleed was reported in 
Tanzania22. Ischemic stroke accounted 
for 73.8% of all patients with stroke in 
Nigerians23. The ongoing AMMP stroke 
incidence study in Tanzania with high 
use of CT will provide more reliable 
estimates of the proportional frequencies 
of stroke types within a community 
setting22.  
Risk Factors for Stroke 
The major risk factors for stroke 
have been extensively investigated and 
reported.  The modification and 
treatment of these risk factors directly 
influence incidence and indirectly affect 
case fatality of stroke, as the natural 
history of the disease is altered.  The 
identification and understanding of the 
magnitude of these stroke determinants 
will go a long way in stroke prevention. 
Studies among Nigerians and other 
populations in developed countries have 
confirmed hypertension as the most 
dominant detriment of stroke24,25,26,27. 
A recent risk factor analysis26 among 
Nigerians revealed hypertension as risk 
factor in 82.5% of stroke patients with 
corresponding odds ratio of 3 and the 
risk of stroke was strongly related to 
both systolic and diastolic blood 
pressure. The relationship between 
blood pressure and risk for first stroke or 
recurrent stroke appears to be log-linear 
throughout normal range of blood 
pressure, with a 10mmHg rise in mean 
arterial pressure (MAP) conferring about 
20% to 30% increase in stroke risk17. It 
is established that stroke risk, especially 
of the hemorrhagic type, is reduced with 
optimal control of blood pressure6.  
Increasing age has been reported to 
be the strongest risk factor for cerebral 
infarction, primary intra-cerebral and 
sub-arachnoid bleed28,29.   The risk of 
stroke increased from 3 per 100,000 by 
third and fourth decade to 8 – 9 per 
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100,000 in the eighth and ninth 
decade27. In sub-Saharan African, most 
cases of stroke occur in relatively young 
people (mean age < 60years in most 
studies), some 10-15 years younger 
than stroke patients in developed 
countries25,30.  The age of occurrence is 
even younger for hemorrhagic stroke 
compared with ischemic stroke17. These 
data indicate a high burden of 
premature stroke in black Africans. 
Sex differences in stroke patients 
have not been consistent but most 
studies showed higher proportion of 
deaths from strokes in men than women 
in all age groups, up to 60-69 years27.  
At older ages mortality is greater for 
females. 
Diabetes mellitus, which has been 
reported in up to 20 – 37% of patients 
with stroke, and cardiac diseases 
especially rheumatic valvular heart 
disease associated with atrial fibrillation 
causing embolic stroke, are common 
determinants of stroke1,13,20,26,28. 
Chronic infection with streptococcal 
pneumonia has been reputed as a risk 
factor for ischemic stroke in Cameroon31. 
Dyslipidemia has been reported among 
stroke patients in South Africa, Burkina 
Faso and Nigeria32,33,34. Other risk 
factors include cigarette smoking, heavy 
alcohol consumption, neuro-syphilis, 
homozygous sickle cell disease (in 
children), obesity, anemia, dehydration, 
infection (including HIV infection), under 
nutrition and congestive heart failure25,26,35,36. 
Limited studies also suggest the 
contribution of cervical spine hyper 
flexion, carotid artery stenosis, cocaine 
abuse, chorionic cancer and hypercoagulable 
states like anti-thrombin III, protein S 
and C deficiency, factor V Leiden and 
prothrombin 202A gene mutation37.  The 
presence of anti-phospholipid antibodies 
and migranous headaches are relatively 
well established risk factors for ischemic 
stroke in young females38.  Transient 
ischemic attacks and family history of 
stroke are important precursors of stroke 
and other vascular ischemic events26. 
Recent studies have highlighted the 
contributions of high fat and sodium 
diets39, and hypokalemia40 to stroke risk. 
Although there may not be a single 
genetic factor associated with stroke, 
genes do play a large role in the 
expression of stroke risk factors such as 
hypertension, heart disease, diabetes, 
and vascular malformations. It is also 
possible that an increased risk for stroke 
within a family is due to environmental 
factors, such as a common sedentary 
lifestyle or poor eating habits, rather 
than hereditary factors. Vascular 
malformations that cause stroke may 
have the strongest genetic link of all 
stroke risk factors. A vascular 
malformation is an abnormally formed 
blood vessel or group of blood vessels. 
One genetic vascular disease called 
CADASIL, which stands for cerebral 
autosomal dominant arteriopathy with 
subcortical infarcts and leukoencephalopathy. 
CADASIL is a rare, genetically inherited, 
congenital vascular disease of the brain 
that causes strokes, subcortical 
dementia, migraine-like headaches, and 
psychiatric disturbances. CADASIL is 
very debilitating and symptoms usually 
surface around the age of 45. Although 
CADASIL can be treated with surgery to 
repair the defective blood vessels, 
patients often die by the age of 6541.  
Current Management Strategies 
Until recently, treatments for stroke 
have consisted of supportive care and 
the prevention of complications. In 
recent years however evidence has 
accumulated to justify a more active 
approach. Experimental and clinical 
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data show that immediately after 
occlusion of a cerebral vessel, cells 
become intensely ischemic leading to 
infarction. As they die, they release a 
range of neuro-active substance and 
enzymes that damage the surrounding 
area. The zone of secondary damage 
represents potentially salvageable 
tissue (penumbra).  The process of 
cerebral infarction may take several 
hours to complete, creating a ‘time 
window’ during which it may be possible 
to restore blood supply to the ischemic 
area of the brain and interrupt or reverse 
the process.  If this can be achieved it 
may be possible to minimize subsequent 
neurological deficit, disability, and secondary 
complications.  Therefore acute stroke is 
regarded as a treatable condition that 
requires urgent specialist attention.  
Both specific treatments and specialist 
care have been shown to influence 
survival and recovery. The approach to 
management depends on the type of 
stroke the patient has and the time of 
presentation. 
The management of stroke patients 
is practically divided into phases; the 
acute phase which includes ambulance 
service and care, emergency room care, 
neuro-intensive care and stroke unit 
management; (2) the sub-acute phase 
management which is mainly supportive 
and takes place in the stroke care ward 
and physiotherapy unit, and (3) chronic 
phase which takes place in the 
community (patient’s house and 
environment) and the outpatient 
clinics11. 
The acute phase is usually in the first 
week and focuses on assessment and 
early supportive care. The sub-acute 
phase, which is between second and 
fourth week, focuses on prevention of 
complications, early rehabilitation, 
psychological support and prevention of 
recurrence.  The chronic phase focuses 
on long term rehabilitation, psychological 
and social support, and prevention of 
recurrence. The management will be 
discussed based on the stroke types 
because of the peculiarities in the 
approach to acute intervention in the 
emergency room and intensive neuro-
critical care. 
Management of ischemic stroke 
The main goal of acute ischemic 
stroke therapy is to reduce infarct size 
which can translate to improved clinical 
outcome and better quality of life.  The 
major advances include the use of 
tissue plasminogen activator, the 
establishment of stroke unit, the use of 
neuro-protective agents and neuro-
endoscopic surgery and transplantation 
of germ cells. Thrombolytic therapy is a 
major step in the acute stroke care. It 
comprises the use of thrombolytic 
agents like rtPA, which is administered 
within 3 to 4.5hours of onset of 
symptoms. Prourokinase is another 
alternative that is used and is given 
within a 6 hour window trial. Neuro-
protective agents are aimed at 
intracellular calcium, free oxygen 
radicals and excitotoxicity (glutamate). 
Stroke Care Unit 
This is a specialized unit with a multi-
disciplinary approach to care of stroke 
patients. It comprises the neurologist, 
neurosurgeon, psychiatrist, physical 
therapist, speech therapist, occupational 
therapist, urologist and social worker. 
The aim of the unit is to render holistic 
care to stroke patients, and it has been 
documented from several meta-
analyses that the stroke unit presence 
improves the survival of patents and 
significantly reduces disability. 
Stroke units are known to improve 
outcome by concentrating patients in a 
unit with appropriate expertise.42  
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Following the dismal and disturbing 
report of the Royal Society of Physicians 
in 2001 revealing the failure of the NHS 
in the United Kingdom to provide 
adequate numbers of beds in stroke 
units, the national clinical guidelines for 
stroke are unequivocal in stating that 
"the evidence in support of stroke unit is 
overwhelming and achieving this should 
be the highest priority of clinicians and 
managers."43 The national service 
framework explicitly recommends that 
"All patients who may have had a stroke 
should be treated by specialist stroke 
teams within designated units."44 This 
effectively means treatment in a stroke 
unit for every person with a stroke. 
Provision of care in a stroke unit is not 
only the practice of evidence based 
medicine but a matter of clinical 
governance. Milestones in the UK 
national service framework specify that 
all general hospitals in United Kingdom 
introduce this model of care from 2004, 
integrated with a stroke prevention 
service, and specialist community 
rehabilitation teams. 
With the implementation of this 
guideline, overall mortality reduced by a 
third, and the 30 day case fatality rate 
fell from 27%45 to 15%.46 Other gains have 
been a low rate of institutionalization, a 
high rate of discharge from the acute 
hospital site, and a rolling educational 
programme for staff.46 Key to the 
success of a unit is influencing bed 
managers to give the stroke unit beds 
the same kind of priority as the coronary 
care unit, and persuading management 
to increase capacity to match need, with 
flexible bed reconfiguration within the 
pool of beds. The number of beds 
actually used for people with strokes 
should meet demand.  
Evidence from randomised 
controlled trials shows that even the 
most disabled patients gain from 
management on a stroke unit, with less 
time spent in hospital and more patients 
going home.47 For patients with a mild 
stroke, stroke units have a role in 
secondary prevention, an area where 
the evidence continually changes and 
needs to be interpreted by a specialist.  
Current evidence shows that there is no 
substitute for management of all strokes 
in a stroke unit. The patients are already 
in the hospital, so what is needed is 
simply reconfiguration of beds and 
training of staff to deliver the care.  
What about the community? The 
sentinel audit shows that only 31% of 
trusts have specialist community stroke 
teams.48 Evidence from randomised 
controlled trials shows that a focused 
community rehabilitation team with 
adequate resources, linking with a state 
of the art stroke unit, reduces length of 
stay and, in moderately and severely 
disabled patients, reduces disability and 
institutional care, compared with 
management by a stroke unit alone49. 




Source: author’s presentation 
Physicians have several diagnostic 
techniques and imaging tools to help 
diagnose the cause of stroke quickly 
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and accurately. The first step in 
diagnosis is a short neurological 
examination. When a possible stroke 
patient arrives at a hospital, a health 
care professional, usually a doctor or 
stroke nurse, will ask the patient or a 
companion what happened and when 
the symptoms began. Blood tests, an 
electrocardiogram, and CT scans will 
often be done. One test that helps 
doctors judge the severity of a stroke 
is the standardized National Institute 
of Health (NIH) Stroke Scale, 
developed by the National Institute for 
Neurological Diseases and Stroke 
(NINDS). Health care professionals 
use the NIH Stroke Scale to measure 
a patient’s neurological deficits by 
asking the patient to answer 
questions and to perform several 
physical and mental tests. Other 
scales include the Glasgow Coma 
Scale, the Hunt and Hess Scale, the 
Modified Rankin Scale, and the 
Barthel Index.  In the emergency 
room, the following steps must be 
taken: 
a. detailed neurological evaluation  
b. assess deficit using the National 
Institute of Health Stroke Scale 
(NIHSS)  
c. check blood sugar  
d. give oxygen 2 – 4L by nasal 
cannula or prongs  
e. administer  dextrose in saline or 
normal saline by intravenous 
route 
f. obtain continuous ECG monitoring  
g. Thereafter an urgent neuro – 
imaging investigative modality is 
sought. 
For patients that present within 3 
hours of stroke onset, there is need to 
determine tPA eligibility. The criteria for 
tPA eligibility Include; 
a. Clinical and CT evidence of 
ischemic stroke 
b. No history of recent trauma or 
major surgery (within the last 
2weeks), Gastro-intestinal or 
Genito-urinary bleed (within the 
last 3 weeks) and no serious 
head injury, brain surgery or 
stroke (within the last 3months) 
c. No evidence of rapidly improving 
symptoms (this suggests a 
possible Transient Ischemic 
Attack) 
d. No seizure at onset (to suggest 
Todd’s paralysis) 
e. Blood pressure greater than 
185/110mmHg without major 
intervention   
f. No CT evidence of intra-cerebral 
hemorrhage  
g. Normal glucose concentration of 
between 50 and 400mg/dl 
h. Prothrombin time less than 15 
seconds  
i. Platelet count greater than 
100,000/mm3. 
Schedule for administration of rtPA 
 
Source: Author’s presentation 
The non-contrast CT is the 
cornerstone of investigation as it detects 
90% of intra-cerebral hemorrhages 
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(ICH) in the first 24hours. It is the 
preferred diagnostic technique for acute 
stroke because of its unique diagnostic 
benefits50. It will quickly rule out a 
hemorrhage, can occasionally show a 
tumor that might mimic a stroke, and 
may even show evidence of early 
infarction. Infarctions generally show up 
on a CT scan about 6 to 8 hours after 
the start of stroke symptoms. 
Hemorrhage is the primary reason for 
avoiding certain drug treatments for 
stroke, such as thrombolytic therapy, the 
only proven acute stroke therapy for 
ischemic stroke. Thrombolytic therapy 
cannot be used until the doctor can 
confidently diagnose the patient as 
suffering from an ischemic stroke 
because this treatment might increase 
bleeding and could make a hemorrhagic 
stroke worse51. 
Other investigations that may be 
useful include computed tomography 
angiography CTA), magnetic resonance 
imaging (MRI), magnetic resonance 
angiography (MRA), carotid duplex, 
cerebral angiography, electro-
cardiography, trans- esophageal 
echocardiography (especially in patients 
suspected to have patent foramen ovale 
- PFO) and coagulation profile. MRI 
uses magnetic fields to detect subtle 
changes in brain tissue content. One 
effect of stroke is an increase of water 
content in the cells of brain tissue, a 
condition called cytotoxic edema. MRI 
can detect edema as soon as a few 
hours after the onset of stroke. The 
benefit of MRI over CT imaging is that 
MRI is better able to detect small 
infarcts soon after stroke onset. 
Arteriography is an X-ray of the carotid 
artery taken when a special dye is 
injected into the artery. The procedure 
carries its own small risk of causing a 
stroke and is costly to perform. The 
benefits of arteriography over MR 
techniques and ultrasound are that it is 
extremely reliable and still the best way 
to measure stenosis of the carotid 
arteries. 
Management of hemorrhagic stroke 
In the management of intracerebral 
bleed, there are two major options; (a) 
medical and (b) surgical. The surgical 
modalities employed are craniotomy or neuro- 
endoscopic surgery. The management of 
intra-cerebral hemorrhage (ICH) remains 
heterogeneous across institutions and 
suffers lack of proven effectiveness 
making its management remains an 
enigma.  Mortality is still as high as 30 – 
40% (i.e. 30 day mortality rare)52. 
In LUTH, Lagos, a mortality of 72% 
was reported53, which was similar to the 
rate in Benin, with acute phase mortality 
of 66.78% and a 3-month mortality rate 
of 79%23. The predicting factors for 
mortality include volume of hematoma, 
neurological states of patients at 
admission (using the Glasgow Gama 
Scale), presence of intra-ventricular or 
sub-arachnoid extension, the presence 
of cerebral oedema23,54,55 and if patient 
is on anti-coagulation therapy56. The 
goal of management is to reduce 
intracranial pressure (i.e. reduce mass 
effect) and potential stimulus for edema 
and cell death54. 
Medically, the cardio-pulmonary 
status of patient is optimized, optimal 
blood pressure control is important and 
measures are taken to reduce intra-
cranial pressure. The following measures 
are instituted in the stroke care unit: 
(i) Patient positioning: the patient 
with ICH should have the head 
elevated to 30 degrees and place 
in neutral position. 
(ii) Measures to reduce elevated 
intracranial pressure – the use of 
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hyperosmolar solutions, barbiturate 
overdose (coma) and hyperventilation. 
(iii)  The blood glucose should be 
optimally stabilized non-aggressively. 
(iv) Specific measures taken to 
reverse coagulation defects. 
Surgery can be used to prevent 
stroke, to treat acute stroke, or to repair 
vascular damage or malformations in 
and around the brain. There are two 
prominent types of surgery for stroke 
prevention and treatment: carotid 
endarterectomy and extracranial/intracranial 
(EC/IC) bypass. The NINDS has 
sponsored two large clinical trials to test 
the efficacy of carotid endarterectomy: 
the North American Symptomatic 
Carotid Endarterectomy Trial (NASCET)57 
and the Asymptomatic Carotid 
Atherosclerosis Trial (ACAS)58. These 
trials showed that carotid 
endarterectomy is a safe and effective 
stroke prevention therapy for most 
people with greater than 50 percent 
stenosis of the carotid arteries when 
performed by a qualified and 
experienced neurosurgeon or vascular 
surgeon. Currently, the NINDS is 
sponsoring the Carotid Revascularization 
Endarterectomy vs. Stenting Trial 
(CREST)59, a large clinical trial designed 
to test the effectiveness of carotid 
endarterectomy versus stenting. The 
procedure involves inserting a long, thin 
catheter tube into an artery in the leg 
and threading the catheter through the 
vascular system into the narrow 
stenosis of the carotid artery in the neck. 
Once the catheter is in place in the 
carotid artery, the radiologist expands 
the stent with a balloon on the tip of the 
catheter. EC/IC bypass surgery is a 
procedure that restores blood flow to a 
blood-deprived area of brain tissue by 
rerouting a healthy artery in the scalp to 
the area of brain tissue affected by a 
blocked artery. The NINDS-sponsored 
EC/IC Bypass Study60 tested the ability 
of this surgery to prevent recurrent 
strokes in stroke patients with 
atherosclerosis. The study showed that, 
in the long run, EC/IC does not seem to 
benefit these patients. The surgery is 
still performed occasionally for patients 
with aneurysms, some types of small 
artery disease, and certain vascular 
abnormalities.  One useful surgical 
procedure for treatment of brain 
aneurysms that cause subarachnoid 
hemorrhage is a technique called 
"clipping." Clipping involves clamping off 
the aneurysm from the blood vessel, 
which reduces the chance that it will 
burst and bleed. A new therapy that is 
gaining wide attention is the detachable 
coil technique for the treatment of high-
risk intracranial aneurysms. A small 
platinum coil is inserted through an 
artery in the thigh and threaded through 
the arteries to the site of the aneurysm. 
The coil is then released into the 
aneurysm, where it evokes an immune 
response from the body. The body 
produces a blood clot inside the 
aneurysm, strengthening the artery 
walls and reducing the risk of rupture. 
Once the aneurysm is stabilized, a 
neurosurgeon can clip the aneurysm 
with less risk of hemorrhage and death 
to the patient. 
Preventive strategies 
Drug therapy is the most common 
treatment for stroke. The most popular 
classes of drugs used to prevent or treat 
stroke are antithrombotics (antiplatelet 
agents and anticoagulants), thrombolytics, 
and neuroprotective agents. Antithrombotics 
prevent the formation of blood clots that 
can become lodged in a cerebral artery 
and cause strokes. Antiplatelet drugs 
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prevent clotting by decreasing the 
activity of platelets, blood cells that 
contribute to the clotting property of 
blood. These drugs reduce the risk of 
blood-clot formation, thus reducing the 
risk of ischemic stroke. In the context of 
stroke, physicians prescribe antiplatelet 
drugs mainly for prevention. The most 
widely known and used antiplatelet drug 
is aspirin. Other antiplatelet drugs 
include clopidogrel, dipyridamole and 
ticlopidine. Anticoagulants reduce stroke 
risk by reducing the clotting property of 
the blood. The most commonly used 
anticoagulants include warfarin and 
heparin. The Stroke Prevention in Atrial 
Fibrillation (SPAF) trial61 found that, 
although aspirin is an effective therapy 
for the prevention of a second stroke in 
most patients with atrial fibrillation, some 
patients with additional risk factors do 
better on warfarin therapy. The Trial of 
Org 10127 in Acute Stroke Treatment 
(TOAST) 62 tested the effectiveness of 
low-molecular weight heparin (Org 
10172) in stroke prevention. TOAST 
showed that heparin anticoagulants are 
not generally effective in preventing 
recurrent stroke or improving outcome.  
Neuroprotectants are medications 
that protect the brain from secondary 
injury caused by stroke. Although only a 
few neuroprotectants are FDA-approved 
for use at this time, many are in clinical 
trials. There are several different 
classes of neuroprotectants that show 
promise for future therapy, including 
calcium antagonists, glutamate antagonists, 
opiate antagonists, antioxidants, apoptosis 
inhibitors, and many others. One of the 
calcium antagonists, nimodipine, also 
called a calcium channel blocker, has 
been shown to decrease the risk of the 
neurological damage that results from 
subarachnoid hemorrhage. Calcium 
channel blockers, such as nimodipine, 
act by reducing the risk of cerebral 
vasospasm, a dangerous side effect of 
subarachnoid hemorrhage in which the 
blood vessels in the subarachnoid 
space constrict erratically, cutting off 
blood flow. 
Rehabilitation Therapy 
Stroke disability is devastating to the 
stroke patient and family, but therapies 
are available to help rehabilitate post-
stroke patients. For most stroke 
patients, physical therapy (PT) is the 
cornerstone of the rehabilitation 
process. A physical therapist uses 
training, exercises, and physical 
manipulation of the stroke patient’s body 
with the intent of restoring movement, 
balance, and coordination. The aim of 
PT is to have the stroke patient relearn 
simple motor activities such as walking, 
sitting, standing, lying down, and the 
process of switching from one type of 
movement to another.  Another type of 
therapy involving relearning daily 
activities is occupational therapy (OT). 
OT also involves exercise and training 
to help the stroke patient relearn 
everyday activities such as eating, 
drinking and swallowing, dressing, 
bathing, cooking, reading and writing, 
and toileting. The goal of OT is to help 
the patient become independent or 
semi-independent. 
Speech and language problems 
arise when brain damage occurs in the 
language centers of the brain. Due to 
the brain’s great ability to learn and 
change (called brain plasticity), other 
areas can adapt to take over some of 
the lost functions. Speech therapy 
helps stroke patients relearn language 
and speaking skills, or learn other 
forms of communication. Speech 
therapy is appropriate for patients who 
have no deficits in cognition or 
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thinking, but have problems 
understanding speech or written 
words, or problems forming speech. A 
speech therapist helps stroke patients 
help themselves by working to improve 
language skills, develop alternative 
ways of communicating, and develop 
coping skills to deal with the frustration 
of not being able to communicate fully. 
With time and patience, a stroke 
survivor should be able to regain 
some, and sometimes all, language 
and speaking abilities. 
Many stroke patients require 
psychological or psychiatric help after 
a stroke. Psychological problems, such 
as depression, anxiety, frustration, and 
anger, are common post-stroke 
disabilities. Talk therapy, along with 
appropriate medication, can help 
alleviate some of the mental and 
emotional problems that result from 
stroke. Sometimes it is also beneficial 
for family members of the stroke 
patient to seek psychological help as 
well.  
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